 |
The Journal of Neuroscience, January 26, 2005, 25(4):914-922; doi:10.1523/JNEUROSCI.4079-04.2005
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Mesolimbic Dopamine Super-Sensitivity in Melanin-Concentrating Hormone-1 Receptor-Deficient Mice
Daniel G. Smith,
Eleni T. Tzavara,
Janice Shaw,
Susan Luecke,
Mark Wade,
Richard Davis,
Craig Salhoff,
George G. Nomikos, and
Donald R. Gehlert
Neuroscience Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285
Melanin-concentrating hormone (MCH) neurons and MCH-1 receptors (MCH1r) densely populate mesolimbic dopaminergic brain regions such as the nucleus accumbens (NAc). The regulation of dopamine by MCH1r was suggested to be an important mechanism underlying the hyperactive phenotype of MCH1r knock-out (ko) mice. However, MCH1r modulation of monoamine neurotransmission has yet to be examined. We tested whether dopamine, norepinephrine, and serotonin function is dysregulated in MCH1r ko and wild-type (wt) mice. MCH1r ko mice exhibited robust hyperactivity in a novel or familiar environment and were super-sensitive to the locomotor activating effects of D-amphetamine and the D1 agonist 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benazepine HCl. The D2 agonist, quinpirole, decreased locomotion similarly in both ko and wt mice. Tissue contents of dopamine within the NAc and caudate-putamen were not significantly different in ko compared with wt mice. Basal and amphetamine-evoked NAc dopamine, norepinephrine, and serotonin efflux, as measured using in vivo microdialysis, were not significantly different between genotypes. In contrast, D1-like and D2-like receptor binding were significantly higher within the olfactory tubercle, ventral tegmental area, and NAc core and shell of ko mice. Norepinephrine transporter (NET) binding was significantly elevated within the NAc shell and globus pallidus of ko mice, whereas serotonin transporter binding was decreased in the NAc shell. Thus, deletion of MCH1r results in an upregulation of mesolimbic dopamine receptors and NET, indicating that MCH1r may negatively modulate mesolimbic monoamine function. MCH1r may be an important therapeutic target for neuropsychiatric disorders involving dysregulation of limbic monoamine systems.
Key words: melanin-concentrating hormone-1 receptor; mesolimbic; nucleus accumbens; dopamine; norepinephrine; hyperactivity; knock-out mice
Received July 29, 2004;
revised December 7, 2004;
accepted December 10, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
M. Bjursell, A. Ahnmark, M. Bohlooly-Y, L. William-Olsson, M. Rhedin, X.-R. Peng, K. Ploj, A.-K. Gerdin, G. Arnerup, A. Elmgren, et al.
Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism
Diabetes,
March 1, 2007;
56(3):
583 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pissios, R. L. Bradley, and E. Maratos-Flier
Expanding the Scales: The Multiple Roles of MCH in Regulating Energy Balance and Other Biological Functions
Endocr. Rev.,
October 1, 2006;
27(6):
606 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bjursell, A.-K. Gerdin, K. Ploj, D. Svensson, L. Svensson, J. Oscarsson, M. Snaith, J. Tornell, and M. Bohlooly-Y
Melanin-Concentrating Hormone Receptor 1 Deficiency Increases Insulin Sensitivity in Obese Leptin-Deficient Mice Without Affecting Body Weight
Diabetes,
March 1, 2006;
55(3):
725 - 733.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|